MedPath

Effect of Osteopathic Manipulative Treatment on Length of Stay in Preterms

Phase 4
Completed
Conditions
Prematurity
Interventions
Other: osteopathic manipulative treatment
Procedure: Usual care
Registration Number
NCT01544257
Lead Sponsor
European Institute for Evidence Based Osteopathic Medicine
Brief Summary

The use of osteopathic manipulative treatment (OMT) in preterm infants has been documented and results from previous studies suggest the association between OMT and length of stay (LOS) reduction, as well as significant improvement in several clinical outcomes. The aim of the present study is to show the effect of OMT on LOS in a sample of premature infants.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • preterm infants born at age between 29 and 37 weeks
  • osteopathic treatment performed < 14 days after birth
  • preterms born in the same hospital
Exclusion Criteria
  • gestational age < 29, > 37 weeks;
  • osteopathic treatment performed > 14 days after birth;
  • newborn transferred to/from other hospital;
  • newborn from to HIV seropositive and/or drug addict mother;
  • newborn with genetic disorders, congenital abnormalities, cardiovascular abnormalities, neurological disorders, proven or suspected necrotizing enterocolitis with or without gastrointestinal perforation, proven or suspected abdominal obstruction, pre- and/or post-surgery patients, pneumoperitoneum and/or atelectasis.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
OMTosteopathic manipulative treatmentpatients under standard medical care plus OMT.
ControlUsual carepatients under standard medical care plus only osteopathic evaluation
Primary Outcome Measures
NameTimeMethod
evaluate the effectiveness of OMT in reducing LOSparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks
Secondary Outcome Measures
NameTimeMethod
pre-post difference in weight gainparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks

Trial Locations

Locations (1)

Francesco Cerritelli

🇮🇹

Pescara, Italy

© Copyright 2025. All Rights Reserved by MedPath